0.21Open0.05Pre Close1 Volume10 Open Interest71.00Strike Price21.00Turnover3432.17%IV8.29%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type-0.0896Delta0.0329Gamma367.57Leverage Ratio-309.8048Theta0.0000Rho-32.95Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet